SE0011205202
SE0011205202
Vitrolife AB
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 12.95B EUR | 11.89B EUR | 12.77B EUR |
Enterprise Value | 13.73B EUR | 12.66B EUR | 13.46B EUR |
Valuation Multiples | |||
Trailing P/E | -- | -- | -- |
Forward P/E | 19.88x | -- | -- |
Price to Sales | 3.82x | 3.47x | 3.74x |
Price to Book | 1.59x | 1.46x | 1.58x |
EV/Revenue | 4.05x | 3.7x | 3.95x |
EV/EBITDA | 13.89x | -- | -- |
Price to FCF (P/FCF) | 23.42x | 24.31x | 28.24x |
EV/FCF | 24.83x | 25.9x | 29.78x |
FCF Yield | 4.27% | 4.11% | 3.54% |